Roger Pomerantz, CEO, Director at ContraFect, holds 126.48K shares in Viracta Therapeutics (Ticker: VIRX), holds 213.98K shares in Seres Therapeutics (Ticker: MCRB), holds 100.00 shares in Rubius Therapeutics (Ticker: RUBY).
What is the percentage of profitable transactions made by Roger Pomerantz?
The percentage of profitable transactions made by Roger Pomerantz is 50%.
What is the average return per transaction made by Roger Pomerantz?
The average return per transaction made by Roger Pomerantz is 13.20%.
What stocks does Roger Pomerantz hold?
Roger Pomerantz holds: CFRXQ, MCRB, RUBY, INDP, VIRX stocks.
What was Roger Pomerantz’s latest transaction?
Roger Pomerantz latest transaction was an Uninformative Buy of $1.40K.
What was Roger Pomerantz's most profitable transaction?
Roger Pomerantz’s most profitable transaction was an Informative Buy of CFRXQ stock on July 26, 2017. The return on the trade was 75.20%.
What is Roger Pomerantz's role in ContraFect?
Roger Pomerantz's role in ContraFect is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.